Search
Powered By HealthLine
Special Offers
Health Tools
 A-Z Symptoms
 Health Centers
 Check A Symptom
 Stress Test
 Health Library
Featured Conditions
 Caregiver
 Skin Care
 Food & Fitness
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Group B Strep Screening Guidelines Sparing Newborns


Related Encyclopedia
 border=
Abscess
Actinomycosis
Acute Myeloid Leukemia (Adult)
AIDS and HIV Infection
More...

Related Healthscout Videos
 border=
Optimistic Healing
Early Babies: How Soon is Too Soon?
Aqua Lipo
Cancer Detection
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Erectile Dysfunction
Facelift
More...

Related Drug Information
 border=
Abilify
Actonel
Augmentin
Bactroban Cream
More...

Related News Articles
 border=
Focusing on School Could Prevent Teen Pregnancies
Low Vitamin D Tied to Estrogen Decline
Caring Through Sharing -- Life Changing Stories
Breast Cancer Pain Continues Years After Treatment
More...


Page:  << Prev | 1 | 2

The authors looked at birth records on 254 infants who had GBS disease and 7,437 infants who did not.

Between 1998-1999 and 2003-2004, screening rates jumped from just over 48 percent to 85 percent. This resulted in almost 32 percent of infants being exposed to antibiotics during delivery in the later timeframe, up from about 27 percent in the late 1990s.

Overall, there were 0.32 cases of GBS per 1,000 live births. Infants born premature had a higher incidence of GBS than infants born full-term (0.73 vs. 0.26 cases per 1,000 live births). Yet, most of the cases occurred in full-term infants.

Text Continues Below



Just over 13 percent of full-term GBS cases occurred in babies of mothers who had not been screened, whereas 61.4 percent occurred in babies of mothers who had actually tested negative for GBS at 35 to 37 weeks of pregnancy.

"Although the antenatal screening strategy has been very successful, we are also exploring ways that we can do even better, and one of them is understanding the issues around false-negatives," Van Dyke said. "While some false-negatives are expected because of the limits of the culture test, we were able to use our study design to show that we observed more false negatives than would be expected."

The term "false-negative" may be a bit of a misnomer, however, Greenberg pointed out.

"If screening is done at 35 weeks gestation, it is possible for a woman who is negative -- i.e., not a carrier -- to become a carrier by the time she delivers," Greenberg said. "Then there's a higher risk that she will pass on group B strep to her infant. Almost all the patients who we see now with group B strep are babies who are born to mothers who had 'false negative' kinds of tests."

One possibility might be to do additional testing later in the pregnancy, Greenberg said. Other instances in which guideline procedures aren't followed involve mothers who come in and deliver too quickly to benefit from antibiotics and women who are allergic to penicillin (although there are other treatment options for these women).

There is also a higher rate of group B strep in black infants than in others, the authors said, but the reasons for this are unclear.

Researchers are still working on a vaccine.

More information

The U.S. Centers for Disease Control and Prevention has more on group B strep.

Page:  << Prev | 1 | 2

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 6/17/2009

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





SOURCES: Melissa K. Van Dyke, Ph.D., epidemiologist, GlaxoSmithKline Biologicals, Rixensart, Belgium; James M. Greenberg, M.D., director, division of neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati; June 18, 2009, New England Journal of Medicine


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy